checkAd

    DGAP-Adhoc  1002  0 Kommentare STADA Arzneimittel AG: Shareholder Meeting resolves to remove supervisory board chairman Dr. Martin Abend from the supervisory board


    STADA Arzneimittel AG / Key word(s): AGM/EGM

    26.08.2016 23:46

    Disclosure of an inside information according to Article 17 MAR,
    transmitted by DGAP - a service of EQS Group AG.
    The issuer is solely responsible for the content of this announcement.

    ---------------------------------------------------------------------------

    Bad Vilbel, August 26, 2016 - The shareholder meeting of STADA Arzneimittel
    AG has today resolved with 55.98 percent of the votes cast to remove the
    chairman of the supervisory board Dr. Martin Abend as a member of the
    company's supervisory board with effect as of the conclusion of the
    shareholder meeting on 26 August 2016.

    All four candidates proposed by the Supervisory Board for election to the
    Supervisory Board, Dr. Birgit Kudlek, Tina Müller, Dr. Gunnar Riemann and
    Rolf Hoffmann have been elected.


    Additional information for analysts:
    STADA Arzneimittel AG / Investor Relations / Stadastraße 2-18 / 61118 Bad
    Vilbel - Germany /
    Tel.: +49 (0) 6101 603-113 / Fax: +49 (0) 6101 603-215 / E-mail:
    ir@stada.de

    Additional information for journalists:
    STADA Arzneimittel AG / Media Relations / Stadastraße 2-18 / 61118 Bad
    Vilbel - Germany /
    Tel.: +49 (0) 6101 603-165 / Fax: +49 (0) 6101 603-215 / E-mail:
    press@stada.de

    Or visit us in the Internet at www.stada.com.


    26.08.2016 The DGAP Distribution Services include Regulatory Announcements,
    Financial/Corporate News and Press Releases.
    Archive at www.dgap.de

    ---------------------------------------------------------------------------

    Language: English
    Company: STADA Arzneimittel AG
    Stadastraße 2-18
    61118 Bad Vilbel
    Germany
    Phone: +49 (0)6101 603- 113
    Fax: +49 (0)6101 603- 506
    E-mail: communications@stada.de
    Internet: www.stada.de
    ISIN: DE0007251803, DE0007251845,
    WKN: 725180, 725184,
    Indices: MDAX
    Listed: Regulated Market in Dusseldorf, Frankfurt (Prime Standard);
    Regulated Unofficial Market in Berlin, Hamburg, Hanover,
    Munich, Stuttgart, Tradegate Exchange

    End of Announcement DGAP News-Service

    ---------------------------------------------------------------------------



    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    DGAP-Adhoc STADA Arzneimittel AG: Shareholder Meeting resolves to remove supervisory board chairman Dr. Martin Abend from the supervisory board STADA Arzneimittel AG / Key word(s): AGM/EGM 26.08.2016 23:46 Disclosure of an inside information according to Article 17 MAR, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. …